Similar Papers

Paper Title
Journal
Date
Author
PANDA: A prospective study of the prevalence of anal dysplasia among women with high-grade cervical, vaginal, and vulvar dysplasia or cancer (107)
Samantha Batman ... Kathleen Schmeler
Gynecologic Oncology | VOL. 166
Samantha Batman, et. al.Samantha Batman ... Kathleen Schmeler
01 Aug 2022
36. Anal cytology and HPV genotyping in women with lower genital tract neoplasia
Katina Robison ... Beth Cronin
Sexual Health | VOL. 10
Katina Robison, et. al.Katina Robison ... Beth Cronin
01 Jan 2013
Long-term follow-up of anal cytology and HPV genotyping among women with lower genital tract neoplasia
Ashley Valenzuela ... Dorothy Buening
Gynecologic Oncology | VOL. 162
Ashley Valenzuela, et. al.Ashley Valenzuela ... Dorothy Buening
01 Aug 2021
Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis
Chunqing Lin ...
The Lancet. Infectious diseases | VOL. 19
Chunqing Lin, et. al.Chunqing Lin ...
13 Jun 2019
View more papers

More From: Gynecologic Oncology

Paper Title
Journal
Date
Author
High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density
Sara Corvigno ... Hanna Dahlstrand
Gynecologic Oncology | VOL. 193
Sara Corvigno, et. al.Sara Corvigno ... Hanna Dahlstrand
01 Feb 2025
Serum CA125 levels in the context of ProMisE molecular classification provides pre-operative prognostic information that can direct endometrial cancer management.
Andrea Neilson ... Jessica N Mcalpine
Gynecologic oncology | VOL. 193
Andrea Neilson, et. al.Andrea Neilson ... Jessica N Mcalpine
01 Feb 2025
What happens after menopause? (WHAM): A prospective controlled study of cognition 24months after premenopausal risk-reducing salpingo-oophorectomy.
Pauline M Maki ... Martha Hickey
Gynecologic oncology | VOL. 193
Pauline M Maki, et. al.Pauline M Maki ... Martha Hickey
01 Feb 2025
Barriers to early detection: Insurance denials for breast MRI screening in women with germline BRCA1/2 mutations
S Gordhandas ... E Aviki
Gynecologic Oncology | VOL. 193
S Gordhandas, et. al.S Gordhandas ... E Aviki
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.